Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.
Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.
复制标题
DOI:
10.1158/1078-0432.ccr-13-2661
复制
发表时间:
2014-11-01
期刊:
影响因子:
--
通讯作者:
Parsons RE
中科院分区:
文献类型:
--
作者:
Hopkins BD;Parsons RE
Phosphatase and Tensin homologue deleted on chromosome ten (PTEN) acts a tumor suppressor through both PI3K dependent and independent mechanisms. Reduced PTEN activity has been shown to affect not only tumor cell proliferation and survival but also impacts the micro-environmental context in which nascent tumors develop. As a result of PTEN’s multifaceted tumor suppressive roles, tumors evolve by selecting for clones in which PTEN activity is lost. PTEN activity within tumors can be modulated in numerous ways including direct mutation, epigenetic regulation, and amplification or mutation of other proteins that can regulate or degrade PTEN. These events functionally prevent PTEN protein from acting within tumor cells. Paracrine roles for PTEN gene products (exosomal PTEN, and PTEN-L) have recently been identified, through which PTEN gene products produced in one cell are able to enter recipient cells and contribute to PTEN functions. In preclinical models purified PTEN-L protein was able to enter tumor xenografts and down regulate PI3K signaling as well as cause tumor cell death. Here we review PTEN’s role as a multifaceted tumor suppressor and reflect upon the potential for PTEN restoration therapy.